Summary

Long COVID significantly impacts the U.S. workforce and economy, with millions unable to return to work months after infection.

A Yale study found 14% of Long COVID patients were unemployed three months post-infection, often due to persistent symptoms.

Globally, Long COVID costs an estimated $1 trillion annually, with U.S. economic losses exceeding $3.7 trillion.

It strains healthcare systems and increases demand for disability benefits. Experts urge investments in Long COVID research, treatment, and prevention, emphasizing vaccination as the most effective tool to mitigate its health and economic toll.